secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001193125-24-011346
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA Biosciences enters $350M at-the-market stock offering with Jefferies
---------------------------------------------------------------------------

- Up to $350M in common stock may be sold from time to time through Jefferies as sales agent.
- Jefferies receives 3% commission on gross proceeds; Company sets sale parameters.
- Shares issued under existing Form S-3 registration statement; prospectus supplement filed Jan 19, 2024.
- ATM program provides at-the-market offering flexibility; no minimum offering amount required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312524011346/0001193125-24-011346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312524011346/d581989d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer